TAM (Treatments and Medicines) NHS Highland
Important: Therapy notes
MHRA advice: Eltrombopag (Revolade): reports of interference with bilirubin and creatinine test results (July 2018) (www.gov.uk).
Important: Formulation and dosage details
Formulation:
Tablets 25mg, 50mg (hospital use only)
Dosage:
As per SMC 1206/17: chronic immune (idiopathic) thrombocytopenic purpura (ITP) patients aged 1 year to 17 years who are refractory to other treatments (eg corticosteroids, immunoglobulins).
SMC restriction: use in patients with severe symptomatic ITP or a high risk of bleeding.